RXP_ConflictInterest_969x267_km_RF
Project

Pew Prescription Project

Status:
Active
Consumer Survey - Disclosure of Industry Payments to Physicians Issue Brief

Consumer Survey - Disclosure of Industry Payments to Physicians

Jun 16, 2008

Americans want to know about physician ties to pharmaceutical companies. More
Subscribe to This Feed
Summary Type

AAMC: The Scientific Basis of Influence and Bias

Issue Brief
  • Feb 5, 2008

The Association of American Medical Colleges recently published "The Scientific Basis of Influence and Bias" based on a symposium held in June 2007 in Washington D.C.

More

Issue Brief

Advancing Integrity in Medical Education

Other Resource
  • May 21, 2013

The Pew Charitable Trusts is working to decrease the influence of pharmaceutical marketing on doctors’ practices. With a three-year grant from the Attorney General Consumer and Prescriber Education Grant Program, Pew is collaborating several partners to improve conflict-of-interest policies within the 158 medical schools and 400 major teaching hospitals in the United States. More

Other Resource

Comments to CMS on Sunshine Implementation

Issue Brief
  • Feb 17, 2012

Pew’s main goals in commenting on the proposed rule are to ensure timely implementation and to promote the interest of full transparency by ensuring that data is collected, reported, and published in the most complete, consistent and accurate manner possible. More

Issue Brief

Consumer Survey - Disclosure of Industry Payments to Physicians

Issue Brief

A majority of Americans say that it is important to know their physician’s financial ties to pharmaceutical companies and support legislation requiring pharmaceutical companies to disclose gifts to doctors.

More

Issue Brief

Disclosure of Industry Payments to Physicians

Report
  • Jun 16, 2008

This Prescription Project survey shows Americans are eager to understand financial ties between physicians and pharmaceutical industry.

More

Report

Expert Profile: Allan Coukell

Video
  • Feb 17, 2012

Allan Coukell, Deputy Director, Medical Programs

More

Video

Federal Reporting Requirements on Payments to Physicians: Impact on State Laws

Issue Brief
  • Nov 12, 2010

With the enactment of the Patient Protection and Affordable Care Act in March 2010,  all U.S. manufacturers of drugs, devices, biologics or medical supplies covered under government-funded insurance programs are now required to report certain information to HHS. This fact sheet describes how these federal reporting requirements affect comparable state disclosure laws.

More

Issue Brief

Joint Comments with Medtronic to CMS on Sunshine Implementation

Issue Brief
  • Feb 17, 2012

The Pew Charitable Trusts “Pew” and Medtronic, Inc. are pleased to jointly comment on the Department of Health and Human Services, Centers for Medicare & Medicaid Services proposed rule implementing Section 6002 of the Affordable Care Act.

More

Issue Brief

Joint Letter to HHS on Sunshine Implementation

Issue Brief
  • Oct 25, 2011

Dear Secretary Sebelius: We are writing to urge you to fully implement Section 1128G of the Social Security Act, the Physician Payments Sunshine Provision, which was added as Section 6002 of the Patient Protection and Affordable Care Act (PPACA).

More

Issue Brief

Legislative text of Physician Payment and other transparency provisions included in H.R. 3590

Issue Brief
  • Mar 22, 2010

Legislative text of Physician Payment and other transparency provisions included in H.R. 3590: Patient Protection and Affordable Care Act of 2009. Passed by the Senate (12/24/09) and the House (3/21/10).

More

Issue Brief

Letter from Pew to CMS Regarding Physician Payments Sunshine Act

Issue Brief
  • May 30, 2013

Prescription project director Danny Carlat identifies issues with the Physician Payments Sunshine Act requiring further clarification and guidance. Addressing those would ensure that manufacturers can appropriately implement the final rule, and enable consumers to benefit from transparency reports published by the Centers for Medicare & Medicaid Services.

More

Issue Brief

MedPAC Recommendations - Public Reporting of Physicians' Financial Relationships

Issue Brief
  • Nov 7, 2008

Final recommendations approved by commission on November 6, 2008 - five recommendations to Congress regarding legislation about disclosure of relationships and gifts and payments made to physicians from pharmaceutical and medical device/supply manufacturers.

More

Issue Brief

Non-physician Prescribers and Pharmaceutical Industry Interactions

Issue Brief
  • Dec 15, 2008

Industry marketing to non-physician prescribers has increased markedly in recent years to roughly 20 million detail visits in 2006, a 20% increase over 2004.

More

Issue Brief

One Step Closer to Medical Transparency: Pew's Analysis of the Final Rule for the Physician Payments Sunshine Act

Other Resource
  • Feb 19, 2013

On Feb. 1, 2013, the Centers for Medicare & Medicaid Services published the final rule guiding implementation of the Physician Payments Sunshine Act, which Congress passed as part of the Affordable Care Act in March 2010 to increase transparency in the relationships between physicians and drug and medical device makers. Here are some of the highlights. More

Other Resource

Persuading the Prescribers: Pharmaceutical Industry Marketing and its Influence on Physicians and Patients

Other Resource
  • Jan 2, 2013

In 2011, the pharmaceutical industry spent nearly $29 billion on drug promotion — more than $25 billion on marketing directly to physicians and almost $4 billion on advertising directly to consumers (mainly through television commercials). This multi-pronged approach is designed to promote its products by influencing doctors’ prescribing practices.

 

More

Other Resource
See More